ClinConnect ClinConnect Logo
Search / Trial NCT05234125

Better Lifestyle Counseling for African American Women During Pregnancy

Launched by UNIVERSITY OF ILLINOIS AT CHICAGO · Jan 31, 2022

Trial Information

Current as of July 25, 2025

Recruiting

Keywords

Sleep, Pregnancy, Intervention, Glucose Metabolism,

ClinConnect Summary

This clinical trial is looking at how a special counseling program can help African American women who are pregnant and have a higher weight. The goal is to see if this program can improve how their bodies manage sugar, which is important for both the mother's and baby's health during pregnancy. The trial is currently recruiting participants, and women who are between 16 and 22 weeks pregnant, overweight (with a body mass index over 25), and who have received prenatal care at The University of Illinois Hospital are encouraged to join.

To be eligible, participants need to be pregnant with one baby, able to speak and understand English, and meet certain health criteria. Women with multiple pregnancies, certain sleep disorders, or specific medical conditions may not be able to participate. Those who join the study can expect to receive personalized support and guidance to help them lead a healthier lifestyle during their pregnancy. This trial aims to address health differences experienced by African American women and improve pregnancy outcomes.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • African American pregnant woman.
  • Women between 16 and 22 GWs.
  • Overweight or obese - pregravid Body Mass Index \>25.0 kg/m2.
  • Singleton gestation.
  • Established prenatal care at The University of Illinois Hospital \& Health Sciences.
  • System Obstetric (UIHHSS' OB) clinics. Able to understand, speak and write in English.
  • Exclusion Criteria:
  • Multiple gestations.
  • Night-shift work.
  • Diagnosed sleep disorders.
  • Known fetal chromosomal or anatomical abnormalities.
  • Diagnosed mood disorders.
  • Gestational diabetes in early pregnancy.
  • Glycated Hemoglobin (HbA1c) ≥ 6.5%.
  • Hypoglycemic medications.
  • Stimulant medication or taking a sleeping aid.
  • Active drug abuse/excessive alcohol intake.

About University Of Illinois At Chicago

The University of Illinois at Chicago (UIC) is a leading academic institution renowned for its commitment to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, UIC harnesses the expertise of its diverse faculty and state-of-the-art facilities to conduct cutting-edge clinical studies aimed at improving patient outcomes. The university's robust infrastructure for clinical research, combined with its dedication to ethical standards and regulatory compliance, positions UIC as a pivotal contributor to the development of new treatments and therapies in various medical fields. Through strategic partnerships and community engagement, UIC strives to translate research findings into real-world applications, enhancing the health and well-being of populations locally and globally.

Locations

Chicago, Illinois, United States

Patients applied

0 patients applied

Trial Officials

Bilgay Izci Balserak, PhD

Principal Investigator

University of Illinois at Chicago

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials